1. Adams JD, Odunze IN (1991) Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Biochem Pharmacol 41: 1099–1105
2. Aime S, Fasano M, Bergamasco B, Lopiano L, Quattrocolo G (1996) Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S (eds) Advances in neurology, vol 69, Parkinson’s disease. Lippincott-Raven, Philadelphia, pp 263–270
3. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, Halliwell B (1997) Oxidative DNA damage in the parkinsonian brain: a selective increase in 8-hydroxyguanine in substantia nigra? J Neurochem 69: 1196–1203
4. Ambani LM, Van Woert MH, Murphy S (1975) Brain peroxides and catalase in Parkinson’s disease. Arch Neurol 32: 114–118
5. Anglade P, Agid Y, Hirsch EC, Vyas S (1997) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 12: 603–610